See all

Gregory M. Lanza, MD, PhD, FACC

Professor of Medicine, Biomedical Engineering, and Biology and Biomedical Sciences

Phone314-454-8635

Emailgreg@cvu.wustl.edu

Additional Titles

  • Co-Founder, Chief Scientific Officer and Board Member, Kereos, Inc. , St. Louis, MO
  • Oliver M. Langenberg Chair, Distinguished Professor of the Science and Practive of Medicine

Related Links

Education

  • Bachelor of Arts: Colby College, Waterville, MN (1975)
  • Masters of Science: Department of Poultry Science, University of Georgia, Athens, GA (1978)
  • Doctor of Philosophy: Department of Poultry Science, University of Georgia, Athens, GA (1981)
  • Doctor of Medicine: Northwestern University Medical School, Chicago, IL (1992)
  • Residency, Medicine: Department of Medicine, Barnes Hospital, Washington University Medical Center, St. Louis, MO (1994)
  • Fellowship, Cardiology: Barnes-Jewish Hospital, Washington University Medical Center, St. Louis, MO (1999)

Board Certifications

  • Cardiovascular Disease

Recognition

Phi Kappa Phi Honor Society
Gamma Sigma Delta Agricultural Honor Society

1997

American Heart Association Fellowship, Missouri Affiliate (1995-1997)
Bristol-Myers Squibb Fellowship Award

1998

Bracco Diagnostics Inc./Society for Cardiac Angiography and Interventions Fellowship
ACC/Littmann Scholarship Award

2000

American College of Cardiology, Searle Career Development Award (2000)

2001

American Heart Association, Missouri Affiliate – Beginning Grant (1999-2001)
Barnes-Jewish Hospital Research Foundation Award (1999-2001)

2003

NCI Unconventional Innovation Program Awards (2000-2003, 2002-2005, 2003-2006)

2005

NCI Unconventional Innovation Program Awards (2000-2003, 2002-2005, 2003-2006)

2006

NCI Unconventional Innovation Program Awards (2000-2003, 2002-2005, 2003-2006)

 

 

Clinical Interests

Noninvasive general adult cardiology with clinical emphasis on cardiovascular imaging with echocardiography and magnetic resonance imaging.

Research Interests

Development of novel nanotechnologies for biomedical molecular imaging (Echo, MRI, CT, Photoacoustic tomography, and optical) and targeted drug delivery (chemotherapeutic, thrombolytic, and siRNA/RNAi) in cardiovascular, neurological, inflammatory, and cancer disease. Design and development of novel prodrugs inclusion in lipid-based nanocolloid agents (including chemotherapeutic, peptides, natural products, synthetic biochemical pathway inhibitors).

Publications

View publications on PubMed.gov